| Product NDC: | 43353-338 | 
| Proprietary Name: | Pantoprazole Sodium | 
| Non Proprietary Name: | pantoprazole sodium | 
| Active Ingredient(s): | 40 mg/1 & nbsp; pantoprazole sodium | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, DELAYED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 43353-338 | 
| Labeler Name: | Aphena Pharma Solutions - Tennessee, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA020987 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20080131 | 
| Package NDC: | 43353-338-53 | 
| Package Description: | 60 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (43353-338-53) | 
| NDC Code | 43353-338-53 | 
| Proprietary Name | Pantoprazole Sodium | 
| Package Description | 60 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (43353-338-53) | 
| Product NDC | 43353-338 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | pantoprazole sodium | 
| Dosage Form Name | TABLET, DELAYED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20080131 | 
| Marketing Category Name | NDA | 
| Labeler Name | Aphena Pharma Solutions - Tennessee, Inc. | 
| Substance Name | PANTOPRAZOLE SODIUM | 
| Strength Number | 40 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |